• Non ci sono risultati.

2 1.3 Bioreactors and in-vitro models

N/A
N/A
Protected

Academic year: 2021

Condividi "2 1.3 Bioreactors and in-vitro models"

Copied!
3
0
0

Testo completo

(1)

Index

Abstract ... a

Chapter 1 ... 1

1.1 Introduction: in-vitro models evolution ... 1

1.2 Evolution of devices ... 2

1.3 Bioreactors and in-vitro models ... 3

1.4 In-vitro relevant models: thesis overview ... 5

Chapter 2 ... 10

2.1 Correlation between in-vitro models and physiology ... 10

2.2 Allometry: the missing link between physiology and in vitro models ... 12

2.3 Allometry and bioreactors ... 14

2.1.1 Surface scaling model (SSM) ... 14

2.1.2 Cell number scaling model (CNSM) ... 18

2.4 Gastro intestinal in vitro model ... 20

2.1.3 CNSM versus SSM: experimental validation ... 21

Chapter 3 ... 25

3.1 Overview of the chapter ... 25

3.2 InLiveTox Project ... 25

3.2.1 System specification ... 26

3.3 ILT1 Bireactor ... 29

3.1.1 Bottom chamber ... 30

(2)

3.1.2 Upper chamber ... 33

3.1.3 Clamp system ... 36

3.4 ILT2 Bireactor ... 37

3.4.1 Holder system ... 38

3.4.2 Bottom chamber ... 40

3.4.3 Upper chamber ... 41

3.4.4 Clamp system ... 43

3.4.5 Plate ... 44

3.5 MCmB 3.0 ... 45

Chapter 4 ... 49

4.1 Models evaluation: ILT1 ... 49

4.1.1 Model A ... 49

4.1.2 Model B ... 52

4.2 Models evaluation and validation: ILT2... 54

4.2.1 Problem solving: liquid passage ... 55

4.2.2 Problem solving: evaluation of NP concentration on the membrane layer . 57 4.3 In-vitro characterization phase of the systems: materials and methods ... 62

4.3.1 ILT1 characterization ... 64

4.3.1.1 Methylene Blue (ILT1) ... 64

4.3.1.2 FITC-PS Nanoparticles ... 67

4.3.1.3 TEER measurement tests ... 69

4.3.2 ILT2 validation ... 71

4.3.2.1 Methylene Blue... 71

4.3.2.2 FITC-PS Nanoparticles ... 74

(3)

4.3.2.3 TEER measurements ... 76

4.3.2.4 Pressure measurements ... 77

4.3.3 MCmB 3.0 validation ... 80

4.3.3.1 Methylene Blue... 80

4.3.3.2 Diclofenac ... 83

4.3.3.3 Urea ... 85

Chapter 5 ... 88

5.1 Overview of in-vitro devices evolution ... 88

5.2 Bioreactor support plate: a new patented device ... 89

5.2.1 Bioreactor plates ... 90

5.2.2 Bioreactor modules ... 94

5.2.3 Control modules ... 97

5.3 System overview.…………...………. 99

Chapter 6 ... 104

6.1 Conclusions: overview ... 104

6.1.1 ILT bioreactors ... 105

6.1.2 Allometry ... 106

6.1.3 Bioreactor support ... 107

6.2 Future improvements ... 108

Bibliography ... 110 Appendix A ... I A.1 ILT1 Protocols ... I Appendix B ... XII B.1 ILT2 Protocols ... XII

Riferimenti

Documenti correlati

[r]

[r]

Si scriva una funzione che riceva come parametri una variabile p di tipo struct persona , un vettore vp di tipo struct persona e la dimensione n del vettore. La funzione

Lampadario, fungaia, cartoleria, stalliere, alimentari, macelleria, furbata, gelato, colpaccio, fratellastro, sorellina, vicinato, angolino, stanchezza, postaccio,

2 Completa le frasi in modo da ottenere periodi contenenti una subordinata soggettiva9. che non tutti

[r]

2) In seguito alla ricezione della richiesta la UOC Scuole di Specializzazione di Area sanitaria provvederà a comunicare (sulla mail personale di Ateneo) l’importo previsto ai

Definizione  dell’integrale  di  Riemann  e  sue  proprietà.  Significato  geometrico.  Teorema  della  media.  Integrale  indefinito:  funzioni  primitive  e